Development of lactococcal GEM-based pneumococcal vaccines

This publication has 51 references indexed in Scilit:

• Epidemiological differences among pneumococcal serotypes
  The Lancet Infectious Diseases, 2005
• Molecular Epidemiology of Pneumococcal Colonization in Response to Pneumococcal Conjugate Vaccination in Children with Recurrent Acute Otitis Media
  Journal of Clinical Microbiology, 2005
• Prevention of Pneumococcal Disease in Mice Immunized with Conserved Surface-Accessible Proteins
  Infection and Immunity, 2004
• PneumococcalSurface Protein A Is Expressed In Vivo, and Antibodies to PspA AreEffective for Therapy in a Murine Model of PneumococcalSepsis
  Infection and Immunity, 2003
• Immunizations with Pneumococcal Surface Protein A and Pneumolysin Are Protective against Pneumonia in a Murine Model of Pulmonary Infection withStreptococcus pneumoniae
  The Journal of Infectious Diseases, 2003
• Decline in Invasive Pneumococcal Disease after the Introduction of Protein–Polysaccharide Conjugate Vaccine
  New England Journal of Medicine, 2003
• Protection against Streptococcus pneumoniae Elicited by Immunization with Pneumolysin and CbpA
  Infection and Immunity, 2001
• Immunization of Mice with Combinations of Pneumococcal Virulence Proteins Elicits Enhanced Protection against Challenge with Streptococcus pneumoniae
  Infection and Immunity, 2000
• Intranasal Immunization of Mice with a Mixture of the Pneumococcal Proteins PsaA and PspA Is Highly Protective against Nasopharyngeal Carriage ofStreptococcus pneumoniae
  Infection and Immunity, 2000
• Intranasal Immunization of Mice with PspA (Pneumococcal Surface Protein A) Can Prevent Intranasal Carriage, Pulmonary Infection, and Sepsis withStreptococcus pneumoniae
  The Journal of Infectious Diseases, 1997